Tenaya Therapeutics, Inc.
USD0.79
-0.00 (-0.53%)
CEO
Faraz Ali
IPO Date
2021-07-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.86
Prev. Close
$0.79
Day Low
$0.76
Day High
$0.86
52W Low
$0.52
52W High
$2.35
Market Cap
$0.13B
Volume
5.33M
| 120,000 |
| $0.80 |
| 29 May 2026 | Stehman-Breen Catherine | director | A-Award | Acquired | 120,000 | $0.80 |
| 29 May 2026 | Srivastava Deepak | director | A-Award | Acquired | 120,000 | $0.80 |
| 29 May 2026 | Parschauer Karah Herdman | director | A-Award | Acquired | 120,000 | $0.80 |
| 29 May 2026 | Lee June | director | A-Award | Acquired | 120,000 | $0.80 |
| 29 May 2026 | Burroughs Amy L. | director | A-Award | Acquired | 120,000 | $0.80 |
| 19 May 2026 | Higa Tomohiro | SVP, Finance | S-Sale | Disposed | 1,485 | $0.79 |
| 19 May 2026 | Ali Faraz | director, officer: Chief Executive Officer | S-Sale | Disposed | 3,390 | $0.79 |
| 19 May 2026 | Tingley Whittemore | Chief Medical Officer | S-Sale | Disposed | 3,121 | $0.79 |